10:05am ET
Health and Healthcare
UBS Loves These 3 Top Biotech Stock Leaders Into Q3 Earnings
Given the massive beat-down in the sector, if these companies surpass earnings expectations, the upside could be sizable.
GILD Coverage Page 32
10:25am ET
Investing
UBS Makes Big Biotech and Pharmaceutical Additions to Equity Focus List
Wikimedia CommonsIf there was ever a time when investors are thrilled to see the calendar change it could be now. With the fourth quarter just starting, many are more than relieved to…
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: AIG, Facebook, Gilead, Google, Regeneron, Twitter, Valeant, Vertex and More
Friday’s top analyst upgrades, downgrades and initiations include AIG, Facebook, Gilead Sciences, Google, Regeneron Pharmaceuticals, Twitter, Valeant Pharmaceuticals and Vertex Pharmaceuticals.
9:25am ET
Health and Healthcare
How the Top Biotechs Handled the Valuation Shock
24/7 Wall St. has taken a look at some of the largest biotech companies and highlighted the damage that a single tweet did to them last week.
8:05am ET
Health and Healthcare
Short Sellers Increase Bets in Major Biotech
The September 15 short interest data have been compared with the previous figures, and short interest in these selected stocks increased across the board for this settlement date.
10:25am ET
Investing
8 Great Value Stocks With Solid Dividends Under 10 Times Earnings
After the sell-off, there are now many more solid and well-established dividend-paying companies valued at less than 10 times earnings.
8:25am ET
Investing
Top Analyst Upgrades and Downgrades: Aetna, Eli Lilly, Gilead, Royal Gold, Sirius XM and Many More
Friday’s top analyst upgrades, downgrades and initiations include Aetna, Eli Lilly, Gilead Sciences, Royal Gold and Sirius XM.
8:05am ET
Health and Healthcare
Short Sellers Increase Bets in Major Biotechs
The short interest data are out for the August 31 settlement date. Short interest in the selected biotech stocks increased across the board for this settlement date.
10:50am ET
Health and Healthcare
Biogen Follows Gilead With Large Debt Offering
ThinkstockAre biotech companies going to become the next big companies saddled with debt? Most likely not, but two debt offerings will stand out to investors here. The first was a $10 billion…
11:10am ET
Health and Healthcare
Why Gilead Faces Unenthusiastic Ratings Into Massive Debt Offering
Gilead Sciences is going to raise cash via a huge debt offering. Will this cash be used to fund a large buyout? Will it be used for stock and/or debt buybacks?
Jon C. Ogg 8:55am ET
Health and Healthcare
Short Sellers Become More Focused in Major Biotechs
The short interest data are out for the August 14 settlement date. Biotech companies are considered a riskier group of stocks.
11:35am ET
Investing
Projected Prices Where Investors Are Interested: Apple, JPMorgan, Ford, GE, Gilead
24/7 Wall St. has wanted to check on the major stocks in the market with an eagle-eye view of where investors may start to buy stocks, as long as they do not…
8:55am ET
Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
The short interest data are out for the July 31 settlement date, and overall, short interest in the selected biotech stocks backed off for this period.
1:27pm ET
Health and Healthcare
Should Gilead Really Be Rated Underperform?
ThinkstockMost analysts seem to be behind the growth that Gilead Sciences Inc. (NASDAQ: GILD) has seen, namely in its Hepatitis C vaccines (HCV) Harvoni and Solvaldi. For the most part the resulting…
8:54am ET
Investing
Top Analyst Upgrades and Downgrades: Amazon, Citrix, Gilead, Sirius XM, 3D Systems, Twitter, Yelp and Many More
Jon OggStocks were indicated higher on Wednesday ahead of the pending FOMC decision on interest rates. Tuesday’s rally was yet another instance where investors proved that they want to buy stocks after…